High throughput discovery and design of enhanced cell lines for next

64x Bio is at the forefront of cell line engineering, focusing on the advancement of cell and gene therapies through innovative high-throughput genome engineering and screening technologies. Their approach integrates computational tools within a design loop, allowing for the creation of highly optimized mammalian cell lines that are essential for the development and manufacturing of next-generation therapeutics. This technology aims to enhance the efficiency and effectiveness of therapeutic solutions, particularly in the context of complex cell and gene therapies.

The company's platform technologies are designed to support pharmaceutical and biotechnology companies, as well as contract development and manufacturing organizations (CDMOs), in their efforts to deliver cell and gene therapies to patients more effectively. By leveraging their advanced engineering capabilities, 64x Bio is positioned to transform the landscape of therapeutic development, making previously unattainable cell lines accessible for the production of innovative treatments.

United States

High throughput engineering of cell lines to enhance the design and manufacture of next-generation therapeutics.

64x Bio

Company Details